<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-049666</identifier>
<setSpec>1699-8855</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">CD10 and malignant mesothelioma. Report of a case</dc:title>
<dc:description xml:lang="en">We report a case of malignant mesothelioma in a 37year-old woman treated for uterine leiomyomas. The diagnosisof mesothelioma was stablished based on autopsystudy. The immunohistochemical study of mesothelialtumor showed strong CD10 immunoreactivity. Our series ofmesotheliomas was also retrospectively studied with anti-CD10 and around 30% of them expressed CD10. Around40% of mestohelioma cases reported in the Literatureexpress CD10. We conclude that CD10 could be expressedin some mesothelial tumors, and may help to stablish a differentialdiagnosis in some cases</dc:description>
<dc:creator>Alameda Quitllet, Francesc</dc:creator>
<dc:creator>Lloreta Trull, Josep</dc:creator>
<dc:creator>Serrano Figueras, Sergi</dc:creator>
<dc:creator>Moysset Agustí, Irene</dc:creator>
<dc:creator>Baró Tomás, Teresa</dc:creator>
<dc:creator>Magán Perea, Luis</dc:creator>
<dc:creator>Badal Alter, Josep</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Aportamos un caso de mesotelioma maligno en unamujer de 37 años con antecedentes de laparoscopia por leiomiomasuterinos. El diagnostico de mesotelioma se estableciópor autopsia. El estudio inmunohistoquímico del tumormesotelial, reveló intensa positividad para CD10, y ausenciade inmunoreactividad para receptores de estrógenos y deprogesterona y calretinina. En nuestra serie de mesoteliomasobservamos que alrededor del 30% de ellos expresabanCD10. En la revisión de la Literatura se observó que aproximadamenteel 40% de los mesoteliomas, mostraban inmunoreactividadpara CD10. En conslusión nuestras observacionesmuestran que CD10 puede expresarse de formaextensa en los mesoteliomas, dato que puede ayudar al establecerun diagnóstico diferencial en estos casos</dc:description>
<dc:source>Rev. esp. patol;39(1): 54-58, abr. 2006. ilus, tab</dc:source>
<dc:identifier>ibc-049666</dc:identifier>
<dc:title xml:lang="es">CD10 y mesotelioma maligno. A propósito de un caso</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d8830^s22053</dc:subject>
<dc:subject>^d23757^s22063</dc:subject>
<dc:subject>^d31266^s22053</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d14995^s22053</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:type>article</dc:type>
<dc:date>200604</dc:date>
</metadata>
</record>
</ibecs-document>
